Essential Education, Tools & Tactics You Can Use Today

Irritable bowel syndrome (IBS) is the most common diagnosis in clinical gastroenterology, affecting an estimated 10% to 15% of the general adult population. IBS and chronic idiopathic constipation (CIC) are disorders of gut-brain interaction, that are common, debilitating, often misunderstood, and a challenge to diagnose and manage. Treatment delays are rampant in patients suffering with IBS and CIC, with many waiting more than three years before seeking treatment for their symptoms. Patients often rely on over-the-counter (OTC) medications or dietary changes to alleviate their symptoms, though for many patients, debilitating symptoms remain or even worsen.

As a chronic, debilitating condition, the need for collaborative care strategies is essential to facilitate the early identification of symptoms, initiation of care, and to optimize long-term management by continuously monitoring symptoms and incorporating stepwise treatment approaches when dietary changes and over-the-counter (OTC) medications fail to provide symptomatic relief. The educational activities on the IBS/CIC Digital Hub have been designed to improve knowledge and performance leading to a confident, accurate diagnosis and prompt treatment of IBS/CIC to improve symptoms and patient quality of life.

Getting to the Gut of the Matter: Closing the Gaps in Diagnosis, Effective Treatment, and Comprehensive Care in IBS and CIC

This enduring material integrates a patient into a faculty panel to provide clinicians with strategies to enhance patient-provider communication to engage patients in discussions about their bowel health and patient-centric treatment strategies that promote symptomatic relief.

Note: Credit is No Longer Available

 

 

Participate Now!

 

Download the Activity Slides – (PDF)

46 Year Old Man Presents with Symptoms of Diarrhea and Abdominal Pain

34 Year Old Woman Presents with Hard Stools and Straining with Defecation over the Past 3-4 Years

Integration of Digital Health Tools

American Gastroenterological Association institute guidelines on the pharmacological management of irritable bowel syndrome.

Weinberg DS, Smalley W, Heidelbaugh, et al. Gastroenterology. 2014;147:1146-1148.

 

American College of Gastroenterology monograph on management of irritable bowel syndrome.

Ford AC, Moayyedi P, Chey WD, et al. Am J Gastroenertol. 2018 Jun 27 doi:
10.1038/s41395-018-0084-x. [Epub ahead of print].

 

Diet and irritable bowel syndrome

Chey WD. Gastroenterol Hepatol (N.Y.). 2018;14(5):309-312.

 

The role of diet in the management of irritable bowel syndrome: a focus of FODMAPs

Dolan R, Chey WD, Eswaran S.
Expert Rev Gastronenterol Hepatol. 2018;12(6):607-615.

 

Rome IV—Functional GI Disorders: Disorders of Gut-Brain Interaction

Drossman DA, Hasler WL. Gastroenterology. 2016;150(6):1257-1492.

 

The gut microbiome and irritable bowel syndrome

Menees S, Chey WD. [version 1; referees: 3 approved]. F1000Research 2018, 7 (F1000 Faculty Rev):1029
(doi: 10.12688/f1000research.14592.1)

 

Bowel disorders

Lacy BE, Mearin F, Chang L, et al. Gastroenterology. 2016;150(6): 1393-1407.